# IGBP1

## Overview
The IGBP1 gene encodes the immunoglobulin binding protein 1, a regulatory protein that plays a pivotal role in cellular signaling pathways, particularly in the regulation of protein phosphatase 2A (PP2A). As an adaptor protein, IGBP1 is involved in modulating the phosphorylation state of various downstream targets, thereby influencing processes such as translation initiation, cellular proliferation, and differentiation. The protein is characterized by its predominantly α-helical structure and contains specific motifs that facilitate interactions with ubiquitin and other proteins, underscoring its role in cellular regulation (Smetana2006Low; McConnell2010Alpha4). IGBP1's interactions with PP2A and other phosphatases are crucial for the regulation of signaling pathways like PI3K/AKT, which are vital for cell fate determination and development (Grech2008Igbp1; Nadel2022GqPCRstimulated). Alterations in the expression or function of IGBP1 have been linked to various clinical conditions, including cancer and neurodevelopmental disorders, highlighting its significance in maintaining cellular homeostasis (Wang2022LncRNA; Grech2008Igbp1).

## Structure
The human IGBP1 protein, also known as α4, exhibits a predominantly α-helical secondary structure, as indicated by circular dichroism (CD) spectra (Smetana2006Low). The protein is elongated in shape, with a more compact and well-structured N-terminal region compared to the flexible C-terminal region, which is suggested to be intrinsically unstructured (Smetana2006Low). This structural flexibility is common in regulatory proteins, allowing IGBP1 to interact with various targets (Smetana2006Low).

IGBP1 contains a ubiquitin-interacting motif (UIM) located between amino acids 46-60, which is crucial for its function as an adaptor protein in the regulation of PP2A ubiquitination (McConnell2010Alpha4). The UIM is characterized by an amphipathic alpha-helix structure, facilitating weak interactions with ubiquitin (McConnell2010Alpha4). The protein's interaction with PP2A is mediated by conserved regions, particularly CR2, which is important for binding due to its positive electrostatic potential (Yang2007The).

IGBP1 is also known to undergo post-translational modifications such as phosphorylation, which may regulate its activity and interactions (Jiang2019High). The protein's structural characteristics, including its flexibility and specific interaction motifs, are essential for its role in cellular signaling and regulation.

## Function
The IGBP1 gene encodes the immunoglobulin binding protein 1, which plays a significant role in cellular signaling pathways, particularly in the regulation of erythroid differentiation and proliferation. IGBP1 is a regulatory subunit of protein phosphatase 2A (PP2A), and it modulates the activity of PP2A, impacting the phosphorylation state of downstream targets such as 4EBP and p70S6 kinase. This modulation is crucial for translation initiation and cellular proliferation processes in erythroblasts (Grech2008Igbp1).

IGBP1 is involved in a positive feedback loop that enhances the recruitment of eIF4E-sensitive mRNAs to polysomes, which is essential for erythropoiesis. Its constitutive expression impairs terminal differentiation of erythroblasts by maintaining phosphorylation levels of 4EBP and p70S6K, even in the presence of erythropoietin (Epo), thus sustaining proliferation and delaying differentiation (Grech2008Igbp1). IGBP1's interaction with PP2A and its role in the PI3K-mTOR-eIF4E pathway highlight its importance in translational control, which is vital for cell fate determination and development (Grech2008Igbp1).

## Clinical Significance
Mutations or altered expression of the IGBP1 gene have been implicated in various clinical conditions, particularly in the context of cancer and neurodevelopmental disorders. In cancer, dysregulation of IGBP1 affects cell proliferation and survival, contributing to tumorigenesis. For instance, in nasopharyngeal carcinoma (NPC), the long non-coding RNA IGBP1-AS1, which is associated with IGBP1, is significantly upregulated. This upregulation promotes NPC growth by targeting miR-150-5p, leading to increased expression of the transcription factor ZEB1, which is involved in cancer cell aggressiveness (Wang2022LncRNA).

IGBP1 is also involved in the regulation of the PI3K/AKT signaling pathway, where it plays a role in the dephosphorylation and inactivation of AKT. This process is crucial for the repression of the PI3K/AKT pathway and can induce apoptosis in a death-receptors-independent manner. Alterations in IGBP1 expression or mutations could potentially impact the regulation of this pathway, influencing cellular processes such as apoptosis and survival, and possibly contributing to cancer development (Nadel2022GqPCRstimulated).

In erythropoiesis, IGBP1 is part of a positive feedback loop that affects mRNA translation initiation, influencing the balance between proliferation and differentiation of erythroblasts. Its dysregulation can impair erythroid differentiation and enhance proliferation, which may have implications in hematological disorders (Grech2008Igbp1).

## Interactions
IGBP1, also known as immunoglobulin binding protein 1, is involved in several protein-protein interactions that play a crucial role in cellular signaling pathways. IGBP1 interacts with the catalytic subunit of protein phosphatase 2A (PP2Ac), forming a dimer that is essential for the regulation of the PI3K/AKT signaling pathway. In resting cells, this dimer binds to PI3K, maintaining high basal activity of the PI3K/AKT pathway. Upon stimulation, the dimer detaches from PI3K and binds to AKT, leading to its dephosphorylation and inactivation (Nadel2022GqPCRstimulated).

IGBP1 also interacts with other phosphatases such as PP4 and PP6, influencing various cellular processes. The interaction between IGBP1 and PP2Ac is mutually exclusive with the binding of A/B subunits due to overlapping binding sites, which displaces these subunits and regulates the distribution of PP2A complexes (Smetana2006Low). IGBP1's structural flexibility, attributed to its intrinsically unstructured regions, allows it to interact with multiple partners, providing a larger binding interface crucial for its regulatory functions (Smetana2006Low).


## References


[1. (Smetana2006Low) Juliana Helena Costa Smetana, Cristiano Luiz Pinto Oliveira, Willy Jablonka, Thelma Aguiar Pertinhez, Flavia Raquel Gonçalves Carneiro, Monica Montero-Lomeli, Iris Torriani, and Nilson Ivo Tonin Zanchin. Low resolution structure of the human α4 protein (igbp1) and studies on the stability of α4 and of its yeast ortholog tap42. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1764(4):724–734, April 2006. URL: http://dx.doi.org/10.1016/j.bbapap.2006.01.018, doi:10.1016/j.bbapap.2006.01.018. This article has 17 citations.](https://doi.org/10.1016/j.bbapap.2006.01.018)

[2. (Grech2008Igbp1) Godfrey Grech, Montserrat Blázquez-Domingo, Andrea Kolbus, Walbert J. Bakker, Ernst W. Müllner, Hartmut Beug, and Marieke von Lindern. Igbp1 is part of a positive feedback loop in stem cell factor–dependent, selective mrna translation initiation inhibiting erythroid differentiation. Blood, 112(7):2750–2760, October 2008. URL: http://dx.doi.org/10.1182/blood-2008-01-133140, doi:10.1182/blood-2008-01-133140. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2008-01-133140)

[3. (Nadel2022GqPCRstimulated) Guy Nadel, Zhong Yao, Ehud Wainstein, Izel Cohen, Ido Ben-Ami, Amir Schajnovitz, Galia Maik-Rachline, Zvi Naor, Benjamin A. Horwitz, and Rony Seger. Gqpcr-stimulated dephosphorylation of akt is induced by an igbp1-mediated pp2a switch. Cell Communication and Signaling, January 2022. URL: http://dx.doi.org/10.1186/s12964-021-00805-z, doi:10.1186/s12964-021-00805-z. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-021-00805-z)

[4. (Jiang2019High) Sicong Jiang, Daojing Li, Zibin Liang, Yanhua Wang, XiaoFeng Pei, and Jianjun Tang. High expression of igbp1 correlates with poor prognosis in esophageal squamous cell carcinoma. The International Journal of Biological Markers, 35(1):33–40, December 2019. URL: http://dx.doi.org/10.1177/1724600819896374, doi:10.1177/1724600819896374. This article has 5 citations.](https://doi.org/10.1177/1724600819896374)

[5. (McConnell2010Alpha4) Jamie L. McConnell, Guy R. Watkins, Sarah E. Soss, Heidi S. Franz, Lisa R. McCorvey, Benjamin W. Spiller, Walter J. Chazin, and Brian E. Wadzinski. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2a ubiquitination. Biochemistry, 49(8):1713–1718, February 2010. URL: http://dx.doi.org/10.1021/bi901837h, doi:10.1021/bi901837h. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi901837h)

[6. (Yang2007The) Jing Yang, S. Mark Roe, Todd D. Prickett, David L. Brautigan, and David Barford. The structure of tap42/α4 reveals a tetratricopeptide repeat-like fold and provides insights into pp2a regulation,. Biochemistry, 46(30):8807–8815, July 2007. URL: http://dx.doi.org/10.1021/bi7007118, doi:10.1021/bi7007118. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi7007118)

[7. (Wang2022LncRNA) Li-Jun Wang, Yan-Sheng Wang, and Ying Zhao. Lncrna igbp1-as1 targets mir-150-5p to increase zeb1 expression in nasopharyngeal carcinoma. Translational Cancer Research, 11(3):530–537, March 2022. URL: http://dx.doi.org/10.21037/tcr-22-291, doi:10.21037/tcr-22-291. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.21037/tcr-22-291)